Phathom Pharmaceuticals (PHAT) Inventory (2023 - 2026)

Phathom Pharmaceuticals (PHAT) has 4 years of Inventory data on file, last reported at $6.5 million in Q1 2026.

• On a quarterly basis, Inventory rose 105.56% year-over-year to $6.5 million in Q1 2026; TTM through Mar 2026 was $6.5 million, a 105.56% increase from a year earlier, with the FY2025 full-year figure at $5.5 million, up 72.01% from the prior year.
• Inventory for Q1 2026 stood at $6.5 million, up from $5.5 million in the prior quarter.
• Over the last five years, Inventory for PHAT reached as high as $6.5 million in Q1 2026 and fell as low as $111000.0 in Q2 2023.
• Historically, Inventory has averaged $2.8 million across 4 years, with a median of $3.1 million in 2024.
• Across the five-year window, Inventory surged 2702.7% in 2024 and climbed 16.07% in 2025, its largest moves.
• Year by year, Inventory stood at $1.2 million in 2023, then jumped by 165.56% to $3.2 million in 2024, then soared by 72.01% to $5.5 million in 2025, then gained by 17.94% to $6.5 million in 2026.
• Per Business Quant data, the three most recent Inventory figures were $6.5 million in Q1 2026, $5.5 million in Q4 2025, and $3.6 million in Q3 2025.